Loading stock data…
HTFL
$29.55+0.03 (+0.12%)
Market OpenUpdated 3:41 PM EDT
HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases the United States and worldwide.
Historical Price
Price (Candle)
Synthesizing Whystock Narrative...
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$29.55
Potential Upside
5%
Whystock Fair Value$31.02
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus6 analysts
Buy
Mean target$37.67+27.5%
Range$35.00 – $43.00
Fundamentals
HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases the United States and worldwide. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personal...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$2.61B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-38.85%
Volume
Today's trading volume
578,211
Recent News
Stanford Trustees Exited HeartFlow Stock for $8.5 Million. Here's What That Means for Investors.
HeartFlow provides AI-driven tools for non-invasive heart diagnostics, serving hospitals and clinics with advanced cardiovascular insights.
Should You Consider Adding Heartflow (HTFL) to Your Portfolio?
Baron Capital, an investment management company, released its Q1 2026 investor letter for the “Baron Discovery Fund”. A copy of the letter can be downloaded here. It was a difficult quarter for Baron Discovery Fund, both on an absolute and relative basis. The Fund declined 10.65% (Institutional Shares) in the quarter, compared to the Russell 2000 […]
A Look At HeartFlow (HTFL) Valuation As Investors Weigh Growth Hopes Against High P/S Multiple
Key metrics and recent trading context With no single headline event driving HeartFlow (HTFL) today, investors are likely focusing on its recent trading pattern, revenue and earnings profile, and the company’s position in non invasive coronary artery disease diagnostics. See our latest analysis for HeartFlow. The recent 1 day and 7 day share price returns of 2.56% and 2.87% sit against a 30 day share price return of 9.69% and a 5.07% year to date gain. This suggests momentum has been...
What Investors Should Know About One HeartFlow Insider's $2 Million Stock Sale
HeartFlow delivers AI-powered cardiac diagnostics to hospitals worldwide; a key insider recently trimmed their stake, SEC filings show.
Heartflow (HTFL) Soars 27% as Firm Guns For Double-Digit Growth
Heartflow Inc. (NASDAQ:HTFL) is one of the 10 Stocks Gaining Momentum Fast. Heartflow jumped by 26.99 percent week-on-week, as investors took heart from its double-digit revenue growth outlook for the year, supported by a strong performance in 2025. In an updated report earlier in the week, the company said that it grew its revenues by […]